Australia markets open in 7 hours 30 minutes

Chewy, Inc. (CHWY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
84.10+2.28 (+2.79%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 534.92B
Enterprise value 334.71B
Trailing P/E N/A
Forward P/E 1300.36
PEG ratio (5-yr expected) 158.68
Price/sales (ttm)4.89
Price/book (mrq)N/A
Enterprise value/revenue 34.86
Enterprise value/EBITDA 7-558.00

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3109.00%
S&P500 52-week change 349.51%
52-week high 3120.00
52-week low 336.65
50-day moving average 387.01
200-day moving average 383.43

Share statistics

Avg vol (3-month) 33.49M
Avg vol (10-day) 34.05M
Shares outstanding 597.92M
Implied shares outstanding 6415.26M
Float 79.77M
% held by insiders 123.36%
% held by institutions 186.24%
Shares short (14 Mar 2021) 411.46M
Short ratio (14 Mar 2021) 43.86
Short % of float (14 Mar 2021) 417.03%
Short % of shares outstanding (14 Mar 2021) 42.76%
Shares short (prior month 11 Feb 2021) 410.45M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jan 2021
Most-recent quarter (mrq)30 Jan 2021

Profitability

Profit margin -1.29%
Operating margin (ttm)-1.27%

Management effectiveness

Return on assets (ttm)-4.23%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)7.15B
Revenue per share (ttm)17.55
Quarterly revenue growth (yoy)50.80%
Gross profit (ttm)1.82B
EBITDA -62.2M
Net income avi to common (ttm)-92.49M
Diluted EPS (ttm)-0.65
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)563.35M
Total cash per share (mrq)1.36
Total debt (mrq)347.37M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.89
Book value per share (mrq)-0.98

Cash flow statement

Operating cash flow (ttm)132.75M
Levered free cash flow (ttm)-676.75k